An association between renal cell carcinoma and lymphoid malignancies: A case series of eight patients

Cancer

Volumn 78, Issue 11, 1996, Pages 2421-2426

  Nishikubo, Carol Y ^a,b   Kunkel, Lori A ^a   Figlin, Robert ^a   Belldegrun, Arie ^a   Rosen, Peter ^a   Elashoff, Robert ^a   Wang, Hejing ^a   Territo, Mary C ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCLA MEDICAL CENTER   (United States)

^c NONE

Author keywords

leukemia; lymphoma; myeloma; renal cell carcinoma

Indexed keywords

CD30 ANTIGEN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUDARABINE; INTERFERON; MELPHALAN; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; BIOPSY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HUMAN; INCIDENCE; KIDNEY CARCINOMA; LEUKEMIA; LYMPHOMA; MALE; MULTIPLE MYELOMA; NEPHRECTOMY; PLASMACYTOSIS; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; WALDENSTROEM MACROGLOBULINEMIA;

AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FATAL OUTCOME; FEMALE; HODGKIN DISEASE; HUMANS; KIDNEY NEOPLASMS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOMA; LYMPHOMA, B-CELL; LYMPHOMA, NON-HODGKIN; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASMS, SECOND PRIMARY; RETROSPECTIVE STUDIES; WALDENSTROM MACROGLOBULINEMIA;

EID: 0029806355     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19961201)78:11<2421::AID-CNCR21>3.0.CO;2-1     Document Type: Article

References (31)

1. De Vita VT, Hellman S, Rosenberg SA, editors. Cancer principles and practice of oncology. 4th edition. Philadelphia: J.B. Lippincott Co., 1993.
2. Haskell CM, Berek JS, editors. Cancer treatment. 4th edition. Philadelphia: W.B. Saunders Co., 1995.
3. Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. CA Cancer J Clin 1995;45:8-30.
4. Maher ER, Bentley E, Yates JR, Barton D, Jennings A, Fellows IW, et al. Mapping of Von Hippel-Lindau disease to chromosome 3p confirmed by genetic linkage analysis. J Neurol Sci 1990;100:27-30.
5. Anglard P, Tory K, Brauch H, Weiss GH, Latif F, Merino MJ, et al. Molecular analysis of genetic changes in the origin and development of renal cell carcinoma. Cancer Res 1991;51: 1071-7.
6. Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, et al. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 1994;7:85-90.
7. Licciardello IT, Spitz MR, Hong WK. Multiple primary cancer in patients with cancer of the head and neck: second cancer of the head and neck, esophagus, and lung. Int J Radiat Oncol Biol Phys 1989;17:467-76.
8. Cooper JS, Pajak TF, Rubin P, Tupchong L, Brady LW, Leibel SA, et al. Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys 1989;17:449-56.
9. Jacobs RH, Yokes EE, Golomb HM. Second malignancies in hairy cell leukemia. Cancer 1985;56:1462-7.
10. Rodriguez MA, Fuller LM, Zimmerman SO, Allen PK, Brown BW, Munsell MF, et al. Hodgkin's disease: study of treatment intensities and incidences of second malignancies. Ann Oncol 1993;4:125-31.
11. Valagussa P. Second neoplasms following treatment of Hodgkin's disease. Curr Opin Oncol 1993;5:805-11.
12. Travis LB, Curtis RE, Boice JD Jr., Hankey BF, Fraumeni JF Jr. Second cancers following non-Hodgkin's lymphoma. Cancer 1991;67:2002-9.
13. Travis LB, Curtis RE, Glimelius B, Holowaty E, Van Leeuwen FE, Lynch CF, et al. Second cancers among long-term survivors of non-Hodgkin's lymphoma. J Natl Cancer Inst 1993;85(23):1932-7.
14. Lavey RS, Eby NL, Prosnitz LR. Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas. Cancer 1990;66:80-8.
15. Smith MB, Xue H, Strong L, Takahashi H, Jaffe N, Ried H, et al. Forty-year experience with second malignancies after treatment of childhood cancer: analysis of outcome following the development of the second malignancy. J Pediatr Surg 1993;28:1342-9.
16. Hartley AL, Birch JM, Blair V, Jones PM, Gattamaneni HR, Kelsey AM. Second primary neoplasms in a population based series of patients diagnosed with renal tumours in childhood. Med Pediatr Oncol 1994;22:318-24.
17. Nielsen B, Braide I, Hasselbalch H. Evidence for an association between hairy cell leukemia and renal cell and colorectal carcinoma. Cancer 1992;70:2087-90.
18. Foa P, Iurlo A, Maiolo AT. Renal cancer after busulphan treatment for chronic myeloid leukemia: therapeutic implications. Ann Oncol 1993;4(6):521-2.
19. Cooper GL, Shaffer DW, Raval HB. Fine needle aspiration biopsy of multiple myeloma in a patient with renal cell carcinoma: a case report. Diagn Cytopathol 1993;9:551-4.
20. Sakai A, Kawano M, Kuramoto A. Interleukin 6 produced by renal cell carcinoma cells and progression of multiple myeloma. N Engl J Med 1991;324:1893-4.
21. Rodriguez Diaz-Pavon J, Pugh W, Cabanillas F. Simultaneous presentation of hairy cell leukemia and follicular small cleaved cell lymphoma in a patient with previous diagnosis of renal cell carcinoma. Hematol Oncol 1995;3:63-7.
22. Lokich JJ. Secondary uncommon solid neoplasms in cured Hodgkin's disease and follow up of the original B-DOPA chemotherapy patient group. Am J Clin Oncol 1990;13(3): 247-50.
23. Davis BE, Sogani PC, Herr HW. Association of primary germ cell tumor of the testis and renal cell carcinoma. J Urol 1993;150:1489-91.
24. Whelan SL, Ferlay J. Age specific and standardized incidence rates. In: Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J, editors. Cancer incidence in five continents. Volume VI. Lyon: World Health Organization International Agency for Research on Cancer and International Association of Cancer Registries, 1992:178-80, 301-9.
25. McDougal WS, Cramer SF, Miller R. Invasive carcinoma of the renal pelvis following cyclophosphamide therapy for nonmalignant disease. Cancer 1981;48:691-5.
26. Brown LM, Gibson R, Blair A, Burmeister LF, Schuman LM, Cantor KP, et al. Smoking and risk of leukemia. Am J Epidemiol 1992;135:763-8.
27. Garfinkel L, Boffetta P. Association between smoking and leukemia in two American Cancer Society prospective studies. Cancer 1990;65:2356-60.
28. Torigoe S, Shuin T, Kubota Y, Horikoshi T, Danenberg K, Danenberg PV. p53 gene mutation in primary human renal cell carcinoma. Oncol Res 1992;4:467-72.
29. Reiter RE, Anglard P, Liu S, Gnarra JR, Linehan WM. Chromosome 17p deletions and p53 mutations in renal cell carcinoma. Cancer Res 1993;53:3092-7.
30. Brauch H, Johnson B, Hovis J, Yano T, Gazdar A, Pettengill OS, et al. Molecular analysis of the short arm of chromosome 3 in small cell and non small cell carcinoma of the lung. N Engl J Med 1987;317:1109-13.
31. Zeiger MA, Gnarra JR, Zbar B, Linehan WM, Pass HI. Loss of heterozygosity on the short arm of chromosome 3 in mesothelioma cell lines and solid tumors. Genes Chromosom Cancer 1994;11:15-20.